These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 32476595

  • 1. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K, Zhou F, Cai X, Chao H, Zhang R, Chen S.
    Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome].
    Cai XH, Chen MY, Chao HY, Jiang NK, Lu XZ, Han WM, Qin W, Jia ZX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):202-208. PubMed ID: 32027277
    [Abstract] [Full Text] [Related]

  • 3. [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
    Qin W, Chen M, Cai X, Chao H, Liu J, Jiang N, Zhou M, Lu X, Chen S, Zhang R, He C, Wang Q.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep 10; 36(9):857-861. PubMed ID: 31515775
    [Abstract] [Full Text] [Related]

  • 4. [Characterization of mutational pattern of patients with core-binding factor acute myeloid leukemia].
    He J, Chao H, Zhou M, Lu X, Chen T, Yang J, Jiang N, Zhang R.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul 10; 36(7):657-661. PubMed ID: 31302905
    [Abstract] [Full Text] [Related]

  • 5. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China.
    Li J, Pei L, Liang S, Xu S, Wang Y, Wang X, Liao Y, Zhan Q, Cheng W, Yang Z, Tang X, Zhang H, Xiao Q, Chen J, Liu L, Wang L.
    Cancer Med; 2023 Apr 10; 12(8):9332-9350. PubMed ID: 36799265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
    Yang L, Wei X, Gong Y.
    Cancer Med; 2024 Jan 10; 13(1):e6871. PubMed ID: 38146893
    [Abstract] [Full Text] [Related]

  • 9. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1.
    Nguyen L, Zhang X, Roberts E, Yun S, McGraw K, Abraham I, Song J, Braswell D, Qin D, Sallman DA, Lancet JE, List AF, Moscinski LC, Padron E, Zhang L.
    Leuk Lymphoma; 2020 Jun 10; 61(6):1395-1405. PubMed ID: 32091281
    [Abstract] [Full Text] [Related]

  • 10. Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia.
    Yu J, Li Y, Li T, Li Y, Xing H, Sun H, Sun L, Wan D, Liu Y, Xie X, Jiang Z.
    Exp Hematol Oncol; 2020 Jun 10; 9():2. PubMed ID: 31921515
    [Abstract] [Full Text] [Related]

  • 11. Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
    Khan M, Cortes J, Kadia T, Naqvi K, Brandt M, Pierce S, Patel KP, Borthakur G, Ravandi F, Konopleva M, Kornblau S, Kantarjian H, Bhalla K, DiNardo CD.
    Int J Mol Sci; 2017 Jul 26; 18(8):. PubMed ID: 28933735
    [Abstract] [Full Text] [Related]

  • 12. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia.
    Bănescu C, Tripon F, Muntean C.
    Int J Mol Sci; 2023 Mar 17; 24(6):. PubMed ID: 36982819
    [Abstract] [Full Text] [Related]

  • 13. [Application of Next Generation Sequencing for AML/MDS Diagnosis and Treatment].
    Cheng HC, Liu SW, Liu Y, Zhao XF, Li W, Qiu L, Ma J.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec 17; 25(6):1631-1635. PubMed ID: 29262888
    [Abstract] [Full Text] [Related]

  • 14. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
    Owattanapanich W, Herzig J, Jahn N, Panina E, Ruchutrakool T, Kungwankiattichai S, Issaragrisil S, Döhner H, Döhner K.
    Ann Hematol; 2021 Aug 17; 100(8):1983-1993. PubMed ID: 33839881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
    Ohgami RS, Ma L, Merker JD, Gotlib JR, Schrijver I, Zehnder JL, Arber DA.
    Mod Pathol; 2015 May 17; 28(5):706-14. PubMed ID: 25412851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.